Kairos Pharma Ltd. (KAPA)
AMEX: KAPA
· Real-Time Price · USD
0.51
-0.06 (-10.53%)
At close: Jun 13, 2025, 3:59 PM
0.55
6.38%
After-hours: Jun 13, 2025, 05:55 PM EDT
-10.53% (1D)
| Bid | 0.51 |
| Market Cap | 8.63M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.54M |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | -2.33 |
| Forward PE | -1.44 |
| Analyst | Buy |
| Ask | 0.58 |
| Volume | 483,350 |
| Avg. Volume (20D) | 686,439 |
| Open | 0.53 |
| Previous Close | 0.57 |
| Day's Range | 0.50 - 0.54 |
| 52-Week Range | 0.40 - 4.00 |
| Beta | 1.18 |
About KAPA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KAPA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KAPA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-23.47%
Kairos Pharma shares are trading lower. The compan...
Unlock content with
Pro Subscription
8 months ago
+0.5%
Kairos Pharma shares are trading higher after the company announced a partnership with PreCheck Health Services to develop biomarkers for targeting cancer drug resistance in prostate and lung cancer.
